Rai G S, Wilkinson R, Taylor R M, Uldall P R, Kerr D N
Clin Nephrol. 1978 May;9(5):194-9.
Between January 1968 and June 1974 at Newcastle upon Tyne, 63 patients underwent splenectomy in association with transplantation; 45 of these had splenectomy with bilateral nephrectomy before (20) or at the time of (25) transplantation; 18 had post-transplant splenectomy for leucopenia. Mortality was significantly higher in splenectomized patients than in 136 non-splenectomized controls. Of the 63 splenectomized patients, 25 died within 1 year of transplantation, 12 of severe infection associated with leucopenia. Although splenectomy produced a temporary rise in white cell count, leucopenia during the first year of immunosuppressive therapy was not significantly less frequent in splenectomized patients than in controls. There was no significant difference in graft loss between the splenectomy and control groups. It is concluded that splenectomy is contra-indicated in patients who are to undergo renal transplantation and confers no benefit when carried out because of leucopenia developing after renal transplantation.
1968年1月至1974年6月期间,在泰恩河畔纽卡斯尔,63例患者在移植手术时接受了脾切除术;其中45例在移植前(20例)或移植时(25例)接受了脾切除术并双侧肾切除术;18例在移植后因白细胞减少接受了脾切除术。脾切除患者的死亡率显著高于136例未接受脾切除的对照组。在63例脾切除患者中,25例在移植后1年内死亡,12例死于与白细胞减少相关的严重感染。尽管脾切除术后白细胞计数暂时升高,但在免疫抑制治疗的第一年,脾切除患者白细胞减少的发生率与对照组相比并没有显著降低。脾切除组和对照组之间的移植肾丢失率没有显著差异。结论是,脾切除术对即将接受肾移植的患者是禁忌的,并且在肾移植后因白细胞减少而进行脾切除时并无益处。